Research archive · This publication is preserved from the LEMMO Cancer Care library. Findings are specific to the study design and population and may not reflect current clinical practice.
Pediatr Blood Cancer. 2005 Jun 15;44(7):679-81.
Whole body hyperthermia in adjuvant therapy of children with renal cell carcinoma.
Ismail-Zade RS, Zhavrid EA, Potapnev MP.
Source
Belarusian Center for Pediatric Oncology and Haemotology, Minsk, Republic of Belarus. reiman1955@mail.ru
Abstract
Whole body hyperthermia (WBH) in combination with chemotherapy has been proven to be effective in some patients with advanced malignancies. However, only limited experience exists regarding the application of WBH with chemotherapy in children. We present the results of applying WBH and chemotherapy in five children with advanced renal cell carcinoma (RCC). WBH (3 hr, 41.8-42.5 degrees C) combined with doxorubicin (50 mg/m2) and interferon-alpha (3 MU/m2) were applied to patients after nephrectomy and lymph node dissection. Each patient received three to eight courses of treatment three times weekly. All children tolerated the combined therapy well without complications. Follow-up of 7-68 months (median: 22 months) showed no tumor progression in patients with locoregional (n = 3) and metastatic (n = 2) disease. WBH with moderate dose doxorubicin and INF-alpha might be a feasible treatment option in childhood RCC.
Copyright 2005 Wiley-Liss, Inc.
Comment in
- Incidental detection of neuroblastoma and “wait and see” strategy. [Pediatr Blood Cancer. 2005]
- Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma. [Pediatr Blood Cancer.